Wednesday, January 29, 2014

The 4-Hour Body

Timothy Ferriss basically turned his body into a laboratory. Having read all sorts of (sometimes conflicting) advice about a range of topics, including losing fat, adding muscle, healing from injuries, and improving sleep, he decided to test them out on himself and a bunch of others. Using the latest technology in advanced gadgetry, he figured out how to dramatically improve his life in many efficient and feasible ways. He gives us his results in The 4-Hour Body.

Thursday, January 23, 2014

The Outsiders

Jack Welch is a highly successful CEO, considered by many to be the greatest CEO of our time. But I would argue that he is considered so because of his charisma, charm and media-savvy. There are actually a number of CEOs who have outperformed him in a big way, but are mostly unassuming and shy from the spotlight. Eight of these are profiled in The Outsiders: Eight Unconventional CEOs and Their Radically Rational Blueprint for Success.

Wednesday, January 22, 2014

Best Buy's Dip Is A Great Opportunity

It was with a heavy heart that I sold my shares of Best Buy in October. Though I had great confidence in new management's ability to continue to improve operations, the company's share price was near fair value in my estimation, and I don't like to own companies without a margin of safety. Since that article in October, however, Best Buy's (BBY) shares are down 43%, offering up another opportunity to own this company at a discount to its intrinsic value.Read more...

Monday, January 20, 2014

Refreshing Dip In The LAKE

Just 8 months ago, Lakeland Industries was brought up on this site as a potential value idea, with its shares trading at a massive discount to the company's net current assets. Today, that discount is no more, as the shares have increased in price by over 80%. As a result, Lakeland is the latest company to join the Value In Action page.

Wednesday, January 15, 2014

Wednesday, January 8, 2014

The Rise and Fall of Modern Medicine

As an investor I generally stay away from companies in the medical field. Not only are they often not in my circle of competence, but they are also usually subject to the whims of governments (patent law, regulations etc), which increases my risk as an investor. Also increasing the investor's risk is that in many cases the nature of the research results in a binary outcome: the company either hits the jackpot or is worthless. I don't have any interest in those types of issues.

Nevertheless, it doesn't mean that I would totally avoid the sector. In every sector, companies will at times trade for prices that are clearly bargains to those even with minimal industry knowledge. With that in mind, I decided to create some of that "minimal knowledge" by reading Le Fanu's The Rise and Fall of Modern Medicine.

Friday, January 3, 2014

Karsan Value Funds: 2013 Q4 Results

Karsan Value Funds (KVF) is a value-oriented fund, as described here. Due to securities regulations, the fund is not open to the public at this time. Should that change in the future, there will be an announcement on this site.

Follow by Email